St. Jude Medical Inc. announced it received a CE mark for its next-generation EnligHTN renal denervation system for treating patients with drug-resistant, uncontrolled hypertension on Aug. 29.
The system features a new generator that delivers simultaneous ablations with a multi-electrode catheter to reduce the ablation time by...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?